Page last updated: 2024-11-05

tranexamic acid and Carcinoma, Renal Cell

tranexamic acid has been researched along with Carcinoma, Renal Cell in 1 studies

Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.

Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gupta, D1
Mishra, S1
Bhatnagar, S1
Jain, V1
Gamanagatti, S1

Other Studies

1 other study available for tranexamic acid and Carcinoma, Renal Cell

ArticleYear
Trial of angioembolization of advanced stage tumors feeding arteries exemplifying aggressive and active interventional palliation.
    Journal of palliative medicine, 2008, Volume: 11, Issue:2

    Topics: Aminocaproates; Antifibrinolytic Agents; Carcinoma, Renal Cell; Embolization, Therapeutic; Humans; K

2008